Vectus Biosystems Limited Vectus Biosystems Limited

Vectus Biosystems Limited

VBS

Rank in Stocks #32116
Vectus Biosystems Limited, an Australian medical research and development firm,... Vectus Biosystems Limited, an Australian medical research and development firm, specializes in devising therapies for fibrotic conditions and hypertension. Its pharmaceutical pipeline addresses ailments affecting the heart, kidneys, liver, and lungs. The company's leading experimental drug, VB0004, aims to counter the degradation of functional tissue resulting from fibrosis, scarring, and elevated blood pressure. Furthermore, Vectus intends to advance treatments for hepatic fibrotic diseases, such as non-alcoholic steatohepatitis, and various pulmonary fibrotic disorders. Beyond its therapeutic endeavors, the company also provides AccuCal and RealCount software, tools engineered to enhance the swiftness and precision of DNA and RNA quantification in laboratory settings. Established in 2005, Vectus Biosystems is headquartered in Rosebery, Australia.
Share Price
$0.03592553
Last synced: 2026-11-16
Market Cap
$1.94M
Change (1 day)
-0.39%
Change (1 year)
-71.45%
Country

Stock data: Financial Modeling PrepΒ·Updated Β·Not investment adviceΒ·How we calculate this

Category

Healthcare
EPS for Vectus Biosystems Limited (VBS)
EPS as of June 2026 TTM: $0.02
According to Vectus Biosystems Limited's latest financial reports, its current EPS (TTM) is $0.02. At the end of 2025 the company had an EPS of $-0.02, an increase over its 2024 EPS of $-0.03.
EPS history for Vectus Biosystems Limited from 2012 to 2026
EPS at the end of each year
Year EPS Change
2026 (TTM) $0.02 -197.50%
2025 $-0.02 -24.91%
2024 $-0.03 -38.83%
2023 $-0.05 -42.15%
2022 $-0.08 -21.14%
2021 $-0.11 17.06%
2020 $-0.09 86.88%
2019 $-0.05 -41.10%
2018 $-0.08 -33.85%
2017 $-0.12 10.30%
2016 $-0.11 20.89%
2015 $-0.09 20.63%
2014 $-0.08 7.89%
2013 $-0.07 -22.49%
2012 $-0.09 0.00%
EPS for similar companies or competitors
Company EPS EPS Difference Country
$15.66 80,207.69%
US
$-7.07 -36,356.41%
US
$-5.29 -27,228.21%
AU
$12.73 65,193.33%
BE
$21.56 110,464.10%
NL

Questions about Vectus Biosystems Limited's earnings per share (EPS)

What is Vectus Biosystems Limited's earnings per share (EPS)?

Vectus Biosystems Limited's earnings per share (EPS) over the last twelve months is $0.02, as of Jun 2026.

What was Vectus Biosystems Limited's earnings per share (EPS) in 2025?

In 2025, Vectus Biosystems Limited's earnings per share (EPS) was $-0.02, compared with $-0.03 in 2024.

How has Vectus Biosystems Limited's earnings per share (EPS) changed since 2020?

From 2020 to 2025, Vectus Biosystems Limited's earnings per share (EPS) was highest in 2025 ($-0.02) and lowest in 2021 ($-0.11).

How does Vectus Biosystems Limited's earnings per share (EPS) compare with similar companies?

Vectus Biosystems Limited's earnings per share (EPS) ($0.02) is higher than that of 2 of the 5 similar companies listed above. The highest among them is Argenx SE, with $21.56.